Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele) in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome - A case report

Angiology

Volumn 51, Issue 4, 2000, Pages 325-329

  Mitsis, Michael ^a,b   Ioannou, Hristos ^a   Eleftheriou, Athanasios ^a   Nousias, Vasilios ^a   Basioukas, Constantinos ^a   Kakosimos, George ^a   Batsis, Charalabos ^a   Vartholomatos, George ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ALLELE; ARTICLE; CASE REPORT; CHROMOSOME 11; DEEP VEIN THROMBOSIS; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MALE; PHLEBITIS; RECURRENT DISEASE;

EID: 0034000356     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005100408     Document Type: Article

References (18)

1. Bertina MR: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43:1678-1683, 1997.
2. Dahlback B: Factor V gene mutation causing inherited resistance to activated C as a basis for venous thromboembolism. J Intern Med 237:221-227, 1995.
3. Adams GJ Jr, Silver D: Deep venous thrombosis and pulmonary embolism - risk factors. In: Current Diagnosis and Treatment in Vascular Surgery, ed. by Dean HR, Yao STJ, Brewster CD. East Norwalk: Appleton & Lang publications, 1995, pp 337-380.
4. Bertina RM, Koeleman BPC, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.
5. Poort SR, Rosendaal FR, Reitsma PH, et al: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
6. Makris M, Preston FE, Beauchamp NJ, et al: Coinheritance of the 20210 allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 78:1426-1429, 1997.
7. Alhenc-Gelas M, Le Camp-Duchez V, Emmerich J, et al: The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gin mutation in thrombophilic families. Blood 90: 1711, 1997.
8. Zoller B, Svensson PJ, Dahlback B, et al: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated Protein C. J Clin Invest 94: 2521-2524, 1994.
9. Arruda VR, Annichino-Bizzachi JM, Goncalves MS, et al: Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Hemost 78:1430-1433, 1997.
10. Rosendaal FR: Risk factors for venous thrombosis: Prevalence, risk and interaction. Semin Hemat 34:171-187, 1997.
11. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of an anticoagulant response to activated protein C. Proc Natl Acad Sci USA 90:1004-1008, 1993.
12. Koster T, Rosendaal FR, Briet E, et al: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342: 1503-1506, 1993.
13. Rees CD, Cox M, Clegg BJ: World distribution of factor V Leiden. Lancet 346:1133-1134, 1995.
14. Mitsis M, Eleftheriou A, loannou H, et al: Genetic defects of factors II and V in the general population and in patients with venous thrombosis. Sixth Greek Congress of Angiology and Vascular Surgery. Athens Jan 22-24, 1999, abstract book, p 83.
15. Bontempo AF, Hassett CA, Faruki H, et al: The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation. J Vasc Surg 25:271-276, 1997.
16. Souto JC, Coll I, Llobet D, et al: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 80:366-369, 1998.
17. Brown K, Luddington R, Williamson D, et al: Risk of venous thromboembolism associated with a G-to-A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol 98: 907-909, 1997.
18. Hillarp A, Zoller B, Svensson PJ, et al: The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78:990-992, 1997.